SIGNIFICANTLY DIFFERENT IMMUNE MICROENVIRONMENT BETWEEN TRIPLE-NEGATIVE BREAST CANCER WITH AND WITHOUT NEOADJUVANT CHEMOTHERAPY THROUGH MULTIPLEX IMMUNOHISTOCHEMISTRY

被引：0
|
作者：
Lee, Miseon [1 ]
Lee, Hyun [2 ]
Gong, Gyungyub [3 ]
Lee, Hee Jin [3 ]
机构：
[1] Seoul St Marys Hosp, Coll Med, Seoul, South Korea
[2] NeogenTC Corp, Gyeonggi Do, Hanam Si, South Korea
[3] Univ Ulsan, Coll Med, Seoul, South Korea
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.0963
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
963
引用
收藏
页码：A1004 / A1004
页数：1
相关论文
共 50 条
  • [21] Triple-Negative Breast Cancer Who Should Receive Neoadjuvant Chemotherapy?
    Chaudhary, Lubna N.
    Wilkinson, K. Hope
    Kong, Amanda
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2018, 27 (01) : 141 - +
  • [22] The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer
    Abraham, Jean E.
    Pinilla, Karen
    Dayimu, Alimu
    Grybowicz, Louise
    Demiris, Nikolaos
    Harvey, Caron
    Drewett, Lynsey M.
    Lucey, Rebecca
    Fulton, Alexander
    Roberts, Anne N.
    Worley, Joanna R.
    Chhabra, Anita
    Qian, Wendi
    Vallier, Anne-Laure
    Hardy, Richard M.
    Chan, Steve
    Hickish, Tamas
    Tripathi, Devashish
    Venkitaraman, Ramachandran
    Persic, Mojca
    Aslam, Shahzeena
    Glassman, Daniel
    Raj, Sanjay
    Borley, Annabel
    Braybrooke, Jeremy P.
    Sutherland, Stephanie
    Staples, Emma
    Scott, Lucy C.
    Davies, Mark
    Palmer, Cheryl A.
    Moody, Margaret
    Churn, Mark J.
    Newby, Jacqueline C.
    Mukesh, Mukesh B.
    Chakrabarti, Amitabha
    Roylance, Rebecca R.
    Schouten, Philip C.
    Levitt, Nicola C.
    Mcadam, Karen
    Armstrong, Anne C.
    Copson, Ellen R.
    Mcmurtry, Emma
    Tischkowitz, Marc
    Provenzano, Elena
    Earl, Helena M.
    NATURE, 2024, 629 (8014) : 1142 - 1148
  • [23] Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer
    Feng Ding
    Ru-Yue Chen
    Jun Hou
    Jing Guo
    Tian-Yi Dong
    World Journal of Clinical Cases, 2022, 10 (12) : 3698 - 3708
  • [24] The immune landscape of residual triple-negative breast cancers after neoadjuvant chemotherapy
    Gonzalez-Ericsson, Paula I.
    Sanchez, Violeta
    Salgado, Roberto
    Bordeaux, Jennifer
    Kim, Ju Y.
    Vaupel, Christine
    Gomez, Henry
    Sanders, Melinda E.
    Balko, Justin M.
    CANCER RESEARCH, 2020, 80 (04)
  • [25] Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer
    Ding, Feng
    Chen, Ru-Yue
    Hou, Jun
    Guo, Jing
    Dong, Tian-Yi
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (12) : 3698 - 3708
  • [26] Triple-Negative Breast Cancer Subclassified by Immunohistochemistry: Correlation with Clinical and Pathological Outcomes in Patients Receiving Neoadjuvant Chemotherapy
    de Paula, Bruno
    Crocamo, Susanne
    de Sousa, Carlos Augusto Moreira
    Valverde, Priscila
    Rezende, Fabiana
    Abdelhay, Eliana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [27] Nanobiotherapeutic strategies to target immune microenvironment of triple-negative breast cancer
    Chang, Qing
    Chang, Liang
    Li, Mo
    Fan, Liwen
    Bao, Shunchao
    Wang, Xinyu
    Liu, Linlin
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (09): : 4083 - 4102
  • [28] Immune microenvironment, homologous recombination deficiency and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: JBCRG22 TR
    Ueno, T.
    Kitano, S.
    Masuda, N.
    Ikarashi, D.
    Yamashita, M.
    Kadoya, T.
    Bando, H.
    Yamanaka, T.
    Ohtani, S.
    Nagai, S.
    Nakayama, T.
    Takahashi, M.
    Saji, S.
    Aogi, K.
    Velaga, R. M.
    Kawaguchi, K.
    Morita, S.
    Haga, H.
    Ohno, S.
    Toi, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S1217 - S1218
  • [29] Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response
    Lejeune, Marylene
    Reverte, Laia
    Sauras, Esther
    Gallardo, Noelia
    Bosch, Ramon
    Roso, Albert
    Petit, Anna
    Peg, Vicente
    Riu, Francisco
    Garcia-Fontgivell, Joan
    Ibanez, Jose
    Relea, Fernanda
    Vieites, Begona
    Bor, Catherine
    de la Cruz-Merino, Luis
    Arenas, Meritxell
    Rodriguez, Valerie
    Galera, Juana
    Korzynska, Anna
    Belhomme, Philippe
    Plancoulaine, Benoit
    alvaro, Tomas
    Lopez, Carlos
    CANCERS, 2023, 15 (03)
  • [30] Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer
    Yam, Clinton
    Yen, Er-Yen
    Chang, Jeffrey T.
    Bassett, Roland L., Jr.
    Alatrash, Gheath
    Garber, Haven
    Huo, Lei
    Yang, Fei
    Philips, Anne, V
    Ding, Qing-Qing
    Lim, Bora
    Ueno, Naoto T.
    Kannan, Kasthuri
    Sun, Xiangjie
    Sun, Baohua
    Cuentas, Edwin Roger Parra
    Symmans, William Fraser
    White, Jason B.
    Ravenberg, Elizabeth
    Seth, Sahil
    Guerriero, Jennifer L.
    Rauch, Gaiane M.
    Damodaran, Senthil
    Litton, Jennifer K.
    Wargo, Jennifer A.
    Hortobagyi, Gabriel N.
    Futreal, Andrew
    Wistuba, Ignacio I.
    Sun, Ryan
    Moulder, Stacy L.
    Mittendorf, Elizabeth A.
    CLINICAL CANCER RESEARCH, 2021, 27 (19) : 5365 - 5375
12345